Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Vector-based SARS-CoV-2 vaccination is associated with improved T-cell responses in hematological neoplasia.
Blood Adv. 2023 Jul 25;7(14):3403-3415. doi: 10.1182/bloodadvances.2022009054.
Blood Adv. 2023.
PMID: 36947191
Free PMC article.
Longitudinal Humoral and Cellular Immune Responses Following SARS-CoV-2 Vaccination in Patients with Myeloid and Lymphoid Neoplasms Compared to a Reference Cohort: Results of a Prospective Trial of the East German Study Group for Hematology and Oncology (OSHO).
Jotschke S, Schulze S, Jaekel N, Ludwig-Kraus B, Engelmann R, Kraus FB, Zahn C, Nedlitz N, Prange-Krex G, Mohm J, Peuser B, Schwarz M, Spohn C, Behlendorf T, Binder M, Junghanss C, Böttcher S, Al-Ali HK.
Jotschke S, et al. Among authors: zahn c.
Cancers (Basel). 2022 Mar 17;14(6):1544. doi: 10.3390/cancers14061544.
Cancers (Basel). 2022.
PMID: 35326695
Free PMC article.
Item in Clipboard
Cite
Cite